Diversity and evolution in the genome of clostridium difficile

Clinical Microbiology Reviews

Volumn 28, Issue 3, 2015, Pages 721-741

  Knight, Daniel R ^a   Elliott, Briony ^b   Chang, Barbara J ^a   Perkins, Timothy T ^a   Riley, Thomas V ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL TRANSMISSION; BACTERIOPHAGE; GENETIC RECOMBINATION; GENOME ANALYSIS; HUMAN; MICROBIAL DIVERSITY; MOLECULAR CLOCK; MOLECULAR EVOLUTION; MOLECULAR PHYLOGENY; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; POINT MUTATION; POLYMERASE CHAIN REACTION; RIBOTYPING; TAXONOMY; BACTERIAL GENOME; CLASSIFICATION; CLOSTRIDIUM INFECTION; GENETIC VARIABILITY; GENETICS; MICROBIOLOGY; PATHOGENICITY; PHYLOGENY;

CLOSTRIDIA; CLOSTRIDIUM DIFFICILE;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; EVOLUTION, MOLECULAR; GENETIC VARIATION; GENOME, BACTERIAL; HUMANS; PHYLOGENY;

EID: 84933505084     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00127-14     Document Type: Article

References (208)

1. Rupnik M, Wilcox MH, Gerding DN. 2009. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 7:526–536. http://dx.doi.org/10.1038/nrmicro2164.
2. Wiegand PN, Nathwani D, Wilcox MH, Stephens J, Shelbaya A, Haider S. 2012. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. J Hosp Infect 81:1–14. http://dx.doi.org/10.1016/j.jhin.2012.02.004.
3. Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/drugresistance/threat-report-2013/.
4. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, Farley MM, Holzbauer SM, Meek JI, Phipps EC, Wilson LE, Winston LG, Cohen JA, Limbago BM, Fridkin SK, Gerding DN, McDonald LC. 2015. Burden of Clostridium difficile infection in the United States. N Engl J Med 372:825–834. http://dx.doi.org/10.1056/NEJMoa1408913.
5. Hall IC, O’Toole E. 1935. Intestinal flora in newborn infants with a description of a new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child 49: 390–402. http://dx.doi.org/10.1001/archpedi.1935.01970020105010.
6. Snyder ML. 1937. Further studies on Bacillus difficilis (Hall and O’Toole). J Infect Dis 60:223–231. http://dx.doi.org/10.1093/infdis/60.2.223.
7. Bartlett JG, Moon N, Chang TW, Taylor N, Onderdonk AB. 1978. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology 75:778–782.
8. Heinlen L, Ballard JD. 2010. Clostridium difficile infection. AmJ Med Sci 340:247–252. http://dx.doi.org/10.1097/MAJ.0b013e3181e939d8.
9. Gebhard RL, Gerding DN, Olson MM, Peterson LR, McClain CJ, Ansel HJ, Shaw MJ, Schwartz ML. 1985. Clinical and endoscopic findings in patients early in the course of Clostridium difficile-associated pseudomembranous colitis. Am J Med 78:45–48. http://dx.doi.org/10.1016/0002-9343(85)90460-7.
10. Gupta A, Patel R, Baddour LM, Pardi DS, Khanna S. 2014. Extraintestinal Clostridium difficile infections: a single-center experience. Mayo Clin Proc 89:1525–1536. http://dx.doi.org/10.1016/j.mayocp.2014.07.012.
11. Eyre DW, Griffiths D, Vaughan A, Golubchik T, Acharya M, O’Connor L, Crook DW, Walker AS, Peto TE. 2013. Asymptomatic Clostridium difficile colonisation and onward transmission. PLoS One 8:e78445. http://dx.doi.org/10.1371/journal.pone.0078445.
12. Bignardi GE. 1998. Risk factors for Clostridium difficile infection. J Hosp Infect 40:1–15. http://dx.doi.org/10.1016/S0195-6701(98)90019-6.
13. Chopra T, Alangaden GJ, Chandrasekar P. 2010. Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients. Expert Rev Anti Infect Ther 8:1113–1119. http://dx.doi.org/10.1586/eri.10.95.
14. Appelbaum PC, Hunter PA. 2000. The fluoroquinolone antibacterials: past, present and future perspectives. Int J Antimicrob Agents 16:5–15. http://dx.doi.org/10.1016/S0924-8579(00)00192-8.
15. Bartlett JG. 2006. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 145:758–764. http://dx.doi.org/10.7326/0003-4819-145-10-200611210-00008.
16. Rutala WA, Gergen MF, Weber DJ. 2012. Efficacy of different cleaning and disinfection methods against Clostridium difficile spores: importance of physical removal versus sporicidal inactivation. Infect Control Hosp Epidemiol 33:1255–1258. http://dx.doi.org/10.1086/668434.
17. Gerding DN, Muto CA, Owens RC, Jr. 2008. Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 46(Suppl 1):S43–S49. http://dx.doi.org/10.1086/521861.
18. Kim KH, Fekety R, Batts DH, Brown D, Cudmore M, Silva J, Jr, Waters D. 1981. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 143:42–50. http://dx.doi.org/10.1093/infdis/143.1.42.
19. Bakken JS, Borody T, Brandt LJ, Brill JV, Demarco DC, Franzos MA, Kelly C, Khoruts A, Louie T, Martinelli LP, Moore TA, Russell G, Surawicz C. 2011. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 9:1044–1049. http://dx.doi.org/10.1016/j.cgh.2011.08.014.
20. Debast SB, Bauer MP, Kuijper EJ. 2014. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 20(Suppl 2):1–26. http://dx.doi.org/10.1111/1469-0691.12418.
21. Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, Gorbach S, Sears P, Shue YK. 2011. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 364:422–431. http://dx.doi.org/10.1056/NEJMoa0910812.
22. Hargreaves KR, Clokie MR. 2014. Clostridium difficile phages: still difficult? Front Microbiol 5:184. http://dx.doi.org/10.3389/fmicb.2014.00184.
23. Gerding DN. 2012. Clostridium difficile infection prevention: biotherapeutics, immunologics, and vaccines. Discov Med 13:75–83.
24. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH. 2010. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 31:431–455. http://dx.doi.org/10.1086/651706.
25. Shen A. 2012. Clostridium difficile toxins: mediators of inflammation. J Innate Immun 4:149–158. http://dx.doi.org/10.1159/000332946.
26. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP. 2010. The role of toxin A and toxin B in Clostridium difficile infection. Nature 467:711–713. http://dx.doi.org/10.1038/nature09397.
27. Voth DE, Ballard JD. 2005. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 18:247–263. http://dx.doi.org/10.1128/CMR.18.2.247-263.2005.
28. Barbut F, Decre D, Lalande V, Burghoffer A, Noussair L, Gigandon A, Espinasse F, Raskine L, Robert J, Mangeol A, Branger C, Petit JC. 2005. Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol 54:181–185. http://dx.doi.org/10.1099/jmm.0.45804-0.
29. Stevenson E, Minton NP, Kuehne SA. 2015. The role of flagella in Clostridium difficile pathogenicity. Trends Microbiol 23:275–282. http://dx.doi.org/10.1016/j.tim.2015.01.004.
30. Cheng V, Yam W, Lam O, Tsang J, Tse E, Siu G, Chan J, Tse H, To K, Tai J. 2011. Clostridium difficile isolates with increased sporulation: emergence of PCR ribotype 002 in Hong Kong. Eur J Clin Microbiol Infect Dis 30:1371–1381. http://dx.doi.org/10.1007/s10096-011-1231-0.
31. Planche T, Wilcox M. 2011. Reference assays for Clostridium difficile infection: one or two gold standards? J Clin Pathol 64:1–5. http://dx.doi.org/10.1136/jcp.2010.080135.
32. Swindells J, Brenwald N, Reading N, Oppenheim B. 2010. Evaluation of diagnostic tests for Clostridium difficile infection. J Clin Microbiol 48:606–608. http://dx.doi.org/10.1128/JCM.01579-09.
33. Knetsch CW, Lawley TD, Hensgens MP, Corver J, Wilcox MW, Kuijper EJ. 2013. Current application and future perspectives of molecular typing methods to study Clostridium difficile infections. Euro Surveill 18(4):pii_20381. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId_20381.
34. Kuijper EJ, van den Berg RJ, Brazier JS. 2009. Comparison of molecular typing methods applied to Clostridium difficile. Methods Mol Biol 551:159–171. http://dx.doi.org/10.1007/978-1-60327-999-4_13.
35. Eyre DW, Fawley WN, Best EL, Griffiths D, Stoesser NE, Crook DW, Peto TE, Walker AS, Wilcox MH. 2013. Comparison of multilocus variable-number tandem-repeat analysis and whole-genome sequencing for investigation of Clostridium difficile transmission. J Clin Microbiol 51:4141–4149. http://dx.doi.org/10.1128/JCM.01095-13.
36. Eyre DW, Walker AS. 2013. Clostridium difficile surveillance: harnessing new technologies to control transmission. Expert Rev Anti Infect Ther 11:1193–1205. http://dx.doi.org/10.1586/14787210.2013.845987.
37. Cairns MD, Stabler RA, Shetty N, Wren BW. 2012. The continually evolving Clostridium difficile species. Future Microbiol 7:945–957. http://dx.doi.org/10.2217/fmb.12.73.
38. Collins DA, Elliott B, Riley TV. 2015. Molecular methods for detecting and typing of Clostridium difficile. Pathology 47:211–218. http://dx.doi.org/10.1097/PAT.0000000000000238.
39. Stubbs SL, Brazier JS, O’Neill GL, Duerden BI. 1999. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37:461–463.
40. Janezic S, Indra A, Rattei T, Weinmaier T, Rupnik M. 2014. Recombination drives evolution of the Clostridium difficile 16S-23S rRNA intergenic spacer region. PLoS One 9:e106545. http://dx.doi.org/10.1371/journal.pone.0106545.
41. Rupnik M. 2008. Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes. FEMS Microbiol Rev 32:541–555. http://dx.doi.org/10.1111/j.1574-6976.2008.00110.x.
42. Rupnik M, Avesani V, Janc M, von Eichel-Streiber C, Delmee M. 1998. A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol 36:2240–2247.
43. Lemee L, Dhalluin A, Pestel-Caron M, Lemeland JF, Pons JL. 2004. Multilocus sequence typing analysis of human and animal Clostridium difficile isolates of various toxigenic types. J Clin Microbiol 42:2609–2617. http://dx.doi.org/10.1128/JCM.42.6.2609-2617.2004.
44. Griffiths D, Fawley W, Kachrimanidou M, Bowden R, Crook DW, Fung R, Golubchik T, Harding RM, Jeffery KJ, Jolley KA, Kirton R, Peto TE, Rees G, Stoesser N, Vaughan A, Walker AS, Young BC, Wilcox M, Dingle KE. 2010. Multilocus sequence typing of Clostridium difficile. J Clin Microbiol 48:770–778. http://dx.doi.org/10.1128/JCM.01796-09.
45. Dingle KE, Griffiths D, Didelot X, Evans J, Vaughan A, Kachrimanidou M, Stoesser N, Jolley KA, Golubchik T, Harding RM, Peto TE, Fawley W, Walker AS, Wilcox M, Crook DW. 2011. Clinical Clostridium difficile: clonality and pathogenicity locus diversity. PLoS One 6:e19993. http://dx.doi.org/10.1371/journal.pone.0019993.
46. Stabler RA, Dawson LF, Valiente E, Cairns MD, Martin MJ, Donahue EH, Riley TV, Songer JG, Kuijper EJ, Dingle KE, Wren BW. 2012. Macro and micro diversity of Clostridium difficile isolates from diverse sources and geographical locations. PLoS One 7:e31559. http://dx.doi.org/10.1371/journal.pone.0031559.
47. Knetsch CW, Terveer EM, Lauber C, Gorbalenya AE, Harmanus C, Kuijper EJ, Corver J, van Leeuwen HC. 2012. Comparative analysis of an expanded Clostridium difficile reference strain collection reveals genetic diversity and evolution through six lineages. Infect Genet Evol 12: 1577–1585. http://dx.doi.org/10.1016/j.meegid.2012.06.003.
48. Eyre DW, Golubchik T, Gordon NC, Bowden R, Piazza P, Batty EM, Ip CL, Wilson DJ, Didelot X, O’Connor L, Lay R, Buck D, Kearns AM, Shaw A, Paul J, Wilcox MH, Donnelly PJ, Peto TE, Walker AS, Crook DW. 2012. A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance. BMJ Open 2:e001124. http://dx.doi.org/10.1136/bmjopen-2012-001124.
49. Walker TM, Ip CL, Harrell RH, Evans JT, Kapatai G, Dedicoat MJ, Eyre DW, Wilson DJ, Hawkey PM, Crook DW, Parkhill J, Harris D, Walker AS, Bowden R, Monk P, Smith EG, Peto TE. 2013. Wholegenome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis 13:137–146. http://dx.doi.org/10.1016/S1473-3099(12)70277-3.
50. Grad YH, Lipsitch M, Feldgarden M, Arachchi HM, Cerqueira GC, Fitzgerald M, Godfrey P, Haas BJ, Murphy CI, Russ C, Sykes S, Walker BJ, Wortman JR, Young S, Zeng Q, Abouelleil A, Bochicchio J, Chauvin S, Desmet T, Gujja S, McCowan C, Montmayeur A, Steelman S, Frimodt-Moller J, Petersen AM, Struve C, Krogfelt KA, Bingen E, Weill FX, Lander ES, Nusbaum C, Birren BW, Hung DT, Hanage WP. 2012. Genomic epidemiology of the Escherichia coli O104:H4 outbreaks in Europe, 2011. Proc Natl Acad SciUSA 109:3065–3070. http://dx.doi.org/10.1073/pnas.1121491109.
51. Mardis E, McPherson J, Martienssen R, Wilson RK, McCombie WR. 2002. What is finished, and why does it matter. Genome Res 12:669–671. http://dx.doi.org/10.1101/gr.032102.
52. Sebaihia M, Wren BW, Mullany P, Fairweather NF, Minton N, Stabler R, Thomson NR, Roberts AP, Cerdeno-Tarrraga AM, Wang HW, Holden MTG, Wright A, Churcher C, Quail MA, Baker S, Bason N, Brooks K, Chillingworth T, Cronin A, Davis P, Dowd L, Fraser A, Feltwell T, Hance Z, Holroyd S, Jagels K, Moule S, Mungall K, Price C, Rabbinowitsch E, Sharp S, Simmonds M, Stevens K, Unwin L, Whithead S, Dupuy B, Dougan G, Barrell B, Parkhill J. 2006. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet 38:779–786. http://dx.doi.org/10.1038/ng1830.
53. Monot M, Boursaux-Eude C, Thibonnier M, Vallenet D, Moszer I, Medigue C, Martin-Verstraete I, Dupuy B. 2011. Reannotation of the genome sequence of Clostridium difficile strain 630. J Med Microbiol 60:1193–1199. http://dx.doi.org/10.1099/jmm.0.030452-0.
54. Gaulton T, Misra R, Rose G, Baybayan P, Hall R, Freeman J, Turton J, Picton S, Korlach J, Gharbia S, Shah H. 2015. Complete genome sequence of the hypervirulent bacterium Clostridium difficile strain G46, ribotype 027. Genome Announc 3(2):e00073-15. http://dx.doi.org/10.1128/genomeA.00073-15.
55. Brouwer MS, Allan E, Mullany P, Roberts AP. 2012. Draft genome sequence of the nontoxigenic Clostridium difficile strain CD37. J Bacteriol 194:2125–2126. http://dx.doi.org/10.1128/JB.00122-12.
56. Stabler RA, He M, Dawson L, Martin M, Valiente E, Corton C, Lawley TD, Sebaihia M, Quail MA, Rose G, Gerding DN, Gibert M, Popoff MR, Parkhill J, Dougan G, Wren BW. 2009. Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol 10:R102. http://dx.doi.org/10.1186/gb-2009-10-9-r102.
57. He M, Sebaihia M, Lawley TD, Stabler RA, Dawson LF, Martin MJ, Holt KE, Seth-Smith HM, Quail MA, Rance R, Brooks K, Churcher C, Harris D, Bentley SD, Burrows C, Clark L, Corton C, Murray V, Rose G, Thurston S, van Tonder A, Walker D, Wren BW, Dougan G, Parkhill J. 2010. Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc Natl Acad Sci U S A 107:7527–7532. http://dx.doi.org/10.1073/pnas.0914322107.
58. Darling AE, Worden P, Chapman TA, Roy Chowdhury P, Charles IG, Djordjevic SP. 2014. The genome of Clostridium difficile 5.3. Gut Pathog 6:4. http://dx.doi.org/10.1186/1757-4749-6-4.
59. Stabler RA, Valiente E, Dawson LF, He M, Parkhill J, Wren BW. 2010. In-depth genetic analysis of Clostridium difficile PCR-ribotype 027 strains reveals high genome fluidity including point mutations and inversions. Gut Microbes 1:269–276. http://dx.doi.org/10.4161/gmic.1.4.11870.
60. Sebaihia M, Peck MW, Minton NP, Thomson NR, Holden MT, Mitchell WJ, Carter AT, Bentley SD, Mason DR, Crossman L, Paul CJ, Ivens A, Wells-Bennik MH, Davis IJ, Cerdeno-Tarraga AM, Churcher C, Quail MA, Chillingworth T, Feltwell T, Fraser A, Goodhead I, Hance Z, Jagels K, Larke N, Maddison M, Moule S, Mungall K, Norbertczak H, Rabbinowitsch E, Sanders M, Simmonds M, White B, Whithead S, Parkhill J. 2007. Genome sequence of a proteolytic (group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes. Genome Res 17:1082–1092. http://dx.doi.org/10.1101/gr.6282807.
61. Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV. 2000. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406:959–964. http://dx.doi.org/10.1038/35023079.
62. Wong YM, Juan JC, Gan HM, Austin CM. 2014. Draft genome sequence of Clostridium bifermentans strain WYM, a promising biohydrogen producer isolated from landfill leachate sludge. Genome Announc 2(2):e00077-14. http://dx.doi.org/10.1128/genomeA.00077-14.
63. Fonknechten N, Chaussonnerie S, Tricot S, Lajus A, Andreesen JR, Perchat N, Pelletier E, Gouyvenoux M, Barbe V, Salanoubat M, Le Paslier D, Weissenbach J, Cohen GN, Kreimeyer A. 2010. Clostridium sticklandii, a specialist in amino acid degradation: revisiting its metabolism through its genome sequence. BMC Genomics 11:555. http://dx.doi.org/10.1186/1471-2164-11-555.
64. Braun V, Hundsberger T, Leukel P, Sauerborn M, von Eichel-Streiber C. 1996. Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene 181:29–38. http://dx.doi.org/10.1016/S0378-1119(96)00398-8.
65. Fluit AC, Wolfhagen MJHM, Verdonk GPHT, Jansze M, Torensma R, Verhoef J. 1991. Nontoxigenic strains of Clostridium difficile lack the genes for both toxin A and toxin B. J Clin Microbiol 29:2666–2667.
66. Mani N, Dupuy B. 2001. Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor. Proc Natl Acad Sci U S A 98:5844–5849. http://dx.doi.org/10.1073/pnas.101126598.
67. Tan KS, Wee BY, Song KP. 2001. Evidence for holin function of tcdE gene in the pathogenicity of Clostridium difficile. J Med Microbiol 50: 613–619.
68. Matamouros S, England P, Dupuy B. 2007. Clostridium difficile toxin expression is inhibited by the novel regulator TcdC. Mol Microbiol 64: 1274–1288. http://dx.doi.org/10.1111/j.1365-2958.2007.05739.x.
69. Curry SR, Marsh JW, Muto CA, O’Leary MM, Pasculle AW, Harrison LH. 2007. tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile. J Clin Microbiol 45:215–221. http://dx.doi.org/10.1128/JCM.01599-06.
70. Carter GP, Douce GR, Govind R, Howarth PM, Mackin KE, Spencer J, Buckley AM, Antunes A, Kotsanas D, Jenkin GA, Dupuy B, Rood JI, Lyras D. 2011. The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile. PLoS Pathog 7:e1002317. http://dx.doi.org/10.1371/journal.ppat.1002317.
71. Bakker D, Smits WK, Kuijper EJ, Corver J. 2012. TcdC does not significantly repress toxin expression in Clostridium difficile 630 delta Erm. PLoS One 7:e43247. http://dx.doi.org/10.1371/journal.pone.0043247.
72. Cartman ST, Kelly ML, Heeg D, Heap JT, Minton NP. 2012. Precise manipulation of the Clostridium difficile chromosome reveals a lack of association between the tcdC genotype and toxin production. Appl Environ Microbiol 78:4683–4690. http://dx.doi.org/10.1128/AEM.00249-12.
73. Stabler RA, Gerding DN, Songer JG, Drudy D, Brazier JS, Trinh HT, Witney AA, Hinds J, Wren BW. 2006. Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J Bacteriol 188:7297–7305. http://dx.doi.org/10.1128/JB.00664-06.
74. Darkoh C, DuPont HL, Norris SJ, Kaplan HB. 2015. Toxin synthesis by Clostridium difficile is regulated through quorum signaling. mBio 6(2): e02569-14. http://dx.doi.org/10.1128/mBio.02569-14.
75. Martin MJ, Clare S, Goulding D, Faulds-Pain A, Barquist L, Browne HP, Pettit L, Dougan G, Lawley TD, Wren BW. 2013. The agr locus regulates virulence and colonization genes in Clostridium difficile 027. J Bacteriol 195:3672–3681. http://dx.doi.org/10.1128/JB.00473-13.
76. Medini D, Donati C, Tettelin H, Masignani V, Rappuoli R. 2005. The microbial pan-genome. Curr Opin Genet Dev 15:589–594. http://dx.doi.org/10.1016/j.gde.2005.09.006.
77. Scaria J, Ponnala L, Janvilisri T, Yan W, Mueller LA, Chang YF. 2010. Analysis of ultra low genome conservation in Clostridium difficile. PLoS One 5:e15147. http://dx.doi.org/10.1371/journal.pone.0015147.
78. Hall BG, Ehrlich GD, Hu FZ. 2010. Pan-genome analysis provides much higher strain typing resolution than multi-locus sequence typing. Microbiology 156:1060–1068. http://dx.doi.org/10.1099/mic.0.035188-0.
79. Forgetta V, Oughton MT, Marquis P, Brukner I, Blanchette R, Haub K, Magrini V, Mardis ER, Gerding DN, Loo VG, Miller MA, Mulvey MR, Rupnik M, Dascal A, Dewar K. 2011. Fourteen-genome comparison identifies DNA markers for severe-disease-associated strains of Clostridium difficile. J Clin Microbiol 49:2230–2238. http://dx.doi.org/10.1128/JCM.00391-11.
80. Janvilisri T, Scaria J, Thompson AD, Nicholson A, Limbago BM, Arroyo LG, Songer JG, Grohn YT, Chang YF. 2009. Microarray identification of Clostridium difficile core components and divergent regions associated with host origin. J Bacteriol 191:3881–3891. http://dx.doi.org/10.1128/JB.00222-09.
81. Lu W, Wise M, Tay C, Windsor H, Marshall B, Peacock C, Perkins T. 2014. Comparative analysis of the full genome of the Helicobacter pylori isolate, Sahul64, identifies genes of high divergence. J Bacteriol 196: 1073–1083. http://dx.doi.org/10.1128/JB.01021-13.
82. Welch RA, Burland V, Plunkett G, III, Redford P, Roesch P, Rasko D, Buckles EL, Liou SR, Boutin A, Hackett J, Stroud D, Mayhew GF, Rose DJ, Zhou S, Schwartz DC, Perna NT, Mobley HL, Donnenberg MS, Blattner FR. 2002. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A 99:17020–17024. http://dx.doi.org/10.1073/pnas.252529799.
83. Hiller NL, Janto B, Hogg JS, Boissy R, Yu SS, Powell E, Keefe R, Ehrlich NE, Shen K, Hayes J, Barbadora K, Klimke W, Dernovoy D, Tatusova T, Parkhill J, Bentley SD, Post JC, Ehrlich GD, Hu FZ. 2007. Comparative genomic analyses of seventeen Streptococcus pneumoniae strains: insights into the pneumococcal supragenome. J Bacteriol 189: 8186–8195. http://dx.doi.org/10.1128/JB.00690-07.
84. Kunin V, Ahren D, Goldovsky L, Janssen P, Ouzounis CA. 2005. Measuring genome conservation across taxa: divided strains and united kingdoms. Nucleic Acids Res 33:616–621. http://dx.doi.org/10.1093/nar/gki181.
85. Yutin N, Galperin MY. 2013. A genomic update on clostridial phylogeny: Gram-negative spore formers and other misplaced clostridia. Environ Microbiol 15:2631–2641. http://dx.doi.org/10.1111/1462-2920.12173.
86. Collins MD, Lawson PA, Willems A, Cordoba JJ, Fernandez- Garayzabal J, Garcia P, Cai J, Hippe H, Farrow JA. 1994. The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. Int J Syst Bacteriol 44:812–826. http://dx.doi.org/10.1099/00207713-44-4-812.
87. Ludwig W, Schleifer KH, Whitman WB. 2009. Revised road map to the phylum Firmicutes, p 1–14. In De Vos P, Garrity GM, Jones D, Krieg NR, Ludwig W, Rainey FA, Schleifer K-H, Whitman WB (ed), Bergey’s manual of systematic bacteriology, 2nd ed, vol 3. The Firmicutes. Springer, New York, NY.
88. Sheridan PP, Freeman KH, Brenchley JE. 2003. Estimated minimal divergence times of the major bacterial and archaeal phyla. Geomicrobiol J 20:1–14. http://dx.doi.org/10.1080/01490450303891.
89. Dingle KE, Didelot X, Ansari MA, Eyre DW, Vaughan A, Griffiths D, Ip CL, Batty EM, Golubchik T, Bowden R, Jolley KA, Hood DW, Fawley WN, Walker AS, Peto TE, Wilcox MH, Crook DW. 2013. Recombinational switching of the Clostridium difficile S-layer and a novel glycosylation gene cluster revealed by large-scale whole-genome sequencing. J Infect Dis 207:675–686. http://dx.doi.org/10.1093/infdis/jis734.
90. Janezic S, Rupnik M. 2015. Genomic diversity of Clostridium difficile strains. Res Microbiol 166:353–360. http://dx.doi.org/10.1016/j.resmic.2015.02.002.
91. Foster NF, Collins DA, Ditchburn SL, Duncan CN, van Schalkwyk JW, Golledge CL, Keed ABR, Riley TV. 2014. Epidemiology of Clostridium difficile infection in two tertiary-care hospitals in Perth, Western Australia: a cross-sectional study. New Microbes New Infect 2:64–71. http://dx.doi.org/10.1002/nmi2.43.
92. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, Monnet DL, van Dissel JT, Kuijper EJ. 2011. Clostridiumdifficile infection in Europe: a hospital-based survey. Lancet 377:63–73. http://dx.doi.org/10.1016/S0140-6736(10)61266-4.
93. Freeman J, Vernon J, Morris K, Nicholson S, Todhunter S, Longshaw C, Wilcox MH. 2015. Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes. Clin Microbiol Infect 20:248.e9–248.e16. http://dx.doi.org/10.1016/j.cmi.2014.09.017.
94. Collins DA, Hawkey PM, Riley TV. 2013. Epidemiology of Clostridium difficile infection in Asia. Antimicrob Resist Infect Control 2:21. http://dx.doi.org/10.1186/2047-2994-2-21.
95. Lim SK, Stuart RL, Mackin KE, Carter GP, Kotsanas D, Francis MJ, Easton M, Dimovski K, Elliott B, Riley TV, Hogg G, Paul E, Korman TM, Seemann T, Stinear TP, Lyras D, Jenkin GA. 2014. Emergence of a ribotype 244 strain of Clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strain. Clin Infect Dis 58:1723–1730. http://dx.doi.org/10.1093/cid/ciu203.
96. Valiente E, Dawson LF, Cairns MD, Stabler RA, Wren BW. 2012. Emergence of new PCR ribotypes from the hypervirulent Clostridium difficile 027 lineage. J Med Microbiol 61:49–56. http://dx.doi.org/10.1099/jmm.0.036194-0.
97. Kuijper EJ, de Weerdt J, Kato H, Kato N, van Dam AP, van der Vorm ER, Weel J, van Rheenen C, Dankert J. 2001. Nosocomial outbreak of Clostridium difficile-associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain. Eur J Clin Microbiol Infect Dis 20:528–534. http://dx.doi.org/10.1007/s100960100550.
98. Drudy D, Harnedy N, Fanning S, Hannan M, Kyne L. 2007. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile. Infect Control Hosp Epidemiol 28:932–940. http://dx.doi.org/10.1086/519181.
99. Alfa MJ, Kabani A, Lyerly D, Moncrief S, Neville LM, Al-Barrak A, Harding GK, Dyck B, Olekson K, Embil JM. 2000. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol 38:2706–2714.
100. Goorhuis A, Legaria MC, van den Berg RJ, Harmanus C, Klaassen CH, Brazier JS, Lumelsky G, Kuijper EJ. 2009. Application of multiple-locus variable-number tandem-repeat analysis to determine clonal spread of toxin A-negative Clostridium difficile in a general hospital in Buenos Aires, Argentina. Clin Microbiol Infect 15:1080–1086. http://dx.doi.org/10.1111/j.1469-0691.2009.02759.x.
101. Jhung MA, Thompson AD, Killgore GE, Zukowski WE, Songer G, Warny M, Johnson S, Gerding DN, McDonald LC, Limbago BM. 2008. ToxinotypeVClostridium difficile in humans and food animals. Emerg Infect Dis 14:1039–1045. http://dx.doi.org/10.3201/eid1407.071641.
102. Elliott B, Dingle KE, Griffiths D, Eyre DW, Crook D, Riley TV. 2012. Australia—home of Clostridium difficile clade 5?, abstr P53. Abstr 4th Int Clostridium difficile Symp, Bled, Slovenia.
103. Knight DR, Thean S, Putsathit P, Fenwick S, Riley TV. 2013. Crosssectional study reveals high prevalence of Clostridium difficile non-PCR ribotype 078 strains in Australian veal calves at slaughter. Appl Environ Microbiol 79:2630–2635. http://dx.doi.org/10.1128/AEM.03951-12.
104. Elliott B, Reed R, Chang BJ, Riley TV. 2009. Bacteremia with a large clostridial toxin-negative, binary toxin-positive strain of Clostridium difficile. Anaerobe 15:249–251. http://dx.doi.org/10.1016/j.anaerobe.2009.08.006.
105. Eckert C, Emirian A, Le Monnier A, Cathala L, De Montclos H, Goret J, Berger P, Petit A, De Chevigny A, Jean-Pierre H. 2015. Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B. New Microbes New Infect 3:12–17. http://dx.doi.org/10.1016/j.nmni.2014.10.003.
106. Androga G, McGovern A, Elliott B, Chang BJ, Perkins T, Foster N, Riley TV. 2015. Evaluation of the Cepheid Xpert C. difficile/Epi and Meridian Bioscience illumigene C. difficile assays for detecting Clostridium difficile ribotype 033 strains. J Clin Microbiol 53:973–975. http://dx.doi.org/10.1128/JCM.03297-14.
107. Dingle KE, Elliott B, Robinson E, Griffiths D, Eyre DW, Stoesser N, Vaughan A, Golubchik T, Fawley WN, Wilcox MH, Peto TE, Walker AS, Riley TV, Crook DW, Didelot X. 2014. Evolutionary history of the Clostridium difficile pathogenicity locus. Genome Biol Evol 6:36–52. http://dx.doi.org/10.1093/gbe/evt204.
108. Kurka H, Ehrenreich A, Ludwig W, Monot M, Rupnik M, Barbut F, Indra A, Dupuy B, Liebl W. 2014. Sequence similarity of Clostridium difficile strains by analysis of conserved genes and genome content is reflected by their ribotype affiliation. PLoS One 9:e86535. http://dx.doi.org/10.1371/journal.pone.0086535.
109. Knetsch CW, Hensgens MP, Harmanus C, van der Bijl MW, Savelkoul PH, Kuijper EJ, Corver J, van Leeuwen HC. 2011. Genetic markers for Clostridium difficile lineages linked to hypervirulence. Microbiology 157: 3113–3123. http://dx.doi.org/10.1099/mic.0.051953-0.
110. Vos M, Didelot X. 2009. A comparison of homologous recombination rates in bacteria and archaea. ISME J 3:199–208. http://dx.doi.org/10.1038/ismej.2008.93.
111. Adams V, Lyras D, Farrow KA, Rood JI. 2002. The clostridial mobilisable transposons. Cell Mol Life Sci 59:2033–2043. http://dx.doi.org/10.1007/s000180200003.
112. Brouwer MS, Warburton PJ, Roberts AP, Mullany P, Allan E. 2011. Genetic organisation, mobility and predicted functions of genes on integrated, mobile genetic elements in sequenced strains of Clostridium difficile. PLoS One 6:e23014. http://dx.doi.org/10.1371/journal.pone.0023014.
113. Roberts AP, Allan E, Mullany P. 2014. The impact of horizontal gene transfer on the biology of Clostridium difficile. Adv Microb Physiol 65: 63–82. http://dx.doi.org/10.1016/bs.ampbs.2014.08.002.
114. Brouwer MS, Roberts AP, Mullany P, Allan E. 2012. In silico analysis of sequenced strains of Clostridium difficile reveals a related set of conjugative transposons carrying a variety of accessory genes. Mob Genet Elements 2:8–12. http://dx.doi.org/10.4161/mge.19297.
115. Goh S, Hussain H, Chang BJ, Emmett W, Riley TV, Mullany P. 2013. Phage C2 mediates transduction of Tn6215, encoding erythromycin resistance, between Clostridium difficile strains. mBio 4(6):e00840-13. http://dx.doi.org/10.1128/mBio.00840-13.
116. Davies J, Davies D. 2010. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 74:417–433. http://dx.doi.org/10.1128/MMBR.00016-10.
117. Roberts AP, Mullany P. 2011. Tn916-like genetic elements: a diverse group of modular mobile elements conferring antibiotic resistance. FEMS Microbiol Rev 35:856–871. http://dx.doi.org/10.1111/j.1574-6976.2011.00283.x.
118. Lyras D, Storie C, Huggins AS, Crellin PK, Bannam TL, Rood JI. 1998. Chloramphenicol resistance in Clostridium difficile is encoded on Tn4453 transposons that are closely related to Tn4451 from Clostridium perfringens. Antimicrob Agents Chemother 42:1563–1567.
119. Mullany P, Pallen M, Wilks M, Stephen JR, Tabaqchali S. 1996. A group II intron in a conjugative transposon from the gram-positive bacterium, Clostridium difficile. Gene 174:145–150. http://dx.doi.org/10.1016/0378-1119(96)00511-2.
120. Spigaglia P, Barbanti F, Mastrantonio P. 2008. Tetracycline resistance gene tet(W) in the pathogenic bacterium Clostridium difficile. Antimicrob Agents Chemother 52:770–773. http://dx.doi.org/10.1128/AAC.00957-07.
121. Mullany P, Wilks M, Tabaqchali S. 1995. Transfer of macrolidelincosamide- streptogramin-B (MLS) resistance in Clostridium difficile is linked to a gene homologous with toxin A and is mediated by a conjugative transposon, Tn5398. J Antimicrob Chemother 35:305–315. http://dx.doi.org/10.1093/jac/35.2.305.
122. Kehrenberg C, Schwarz S, Jacobsen L, Hansen LH, Vester B. 2005. A new mechanism for chloramphenicol, florfenicol and clindamycin resistance: methylation of 23S ribosomal RNA at A2503. Mol Microbiol 57: 1064–1073. http://dx.doi.org/10.1111/j.1365-2958.2005.04754.x.
123. Kehrenberg C, Schwarz S. 2006. Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates. Antimicrob Agents Chemother 50:1156–1163. http://dx.doi.org/10.1128/AAC.50.4.1156-1163.2006.
124. Marin M, Martin A, Alcala L, Cercenado E, Iglesias C, Reigadas E, Bouza E. 2015. Clostridium difficile isolates with high linezolid MICs harbor the multiresistance gene cfr. Antimicrob Agents Chemother 59: 586–589. http://dx.doi.org/10.1128/AAC.04082-14.
125. Corver J, Bakker D, Brouwer MS, Harmanus C, Hensgens MP, Roberts AP, Lipman LJ, Kuijper EJ, van Leeuwen HC. 2012. Analysis of a Clostridium difficile PCR ribotype 078 100 kilobase island reveals the presence of a novel transposon, Tn6164. BMC Microbiol 12:130. http://dx.doi.org/10.1186/1471-2180-12-130.
126. Spigaglia P, Barbanti F, Mastrantonio P. 2011. Multidrug resistance in European Clostridium difficile clinical isolates. J Antimicrob Chemother 66:2227–2234. http://dx.doi.org/10.1093/jac/dkr292.
127. He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, Martin MJ, Connor TR, Harris SR, Fairley D, Bamford KB, D’Arc S, Brazier J, Brown D, Coia JE, Douce G, Gerding D, Kim HJ, Koh TH, Kato H, Senoh M, Louie T, Michell S, Butt E, Peacock SJ, Brown NM, Riley TV, Songer G, Wilcox MH, Pirmohamed M, Kuijper E, Hawkey P, Wren BW, Dougan G, Parkhill J, Lawley TD. 2013. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet 45:109–113. http://dx.doi.org/10.1038/ng.2478.
128. Wasels F, Monot M, Spigaglia P, Barbanti F, Ma L, Bouchier C, Dupuy B, Mastrantonio P. 2014. Inter- and intraspecies transfer of a Clostridium difficile conjugative transposon conferring resistance to MLSB. Microb Drug Resist 20:555–560. http://dx.doi.org/10.1089/mdr.2014.0015.
129. van Eijk E, Anvar S, Browne HP, Leung W, Frank J, Schmitz AM, Roberts AP, Smits W. 2015. Complete genome sequence of the Clostridium difficile laboratory strain 630 Δerm reveals differences from strain 630, including translocation of the mobile element CTn 5. BMCGenomics 16:31. http://dx.doi.org/10.1186/s12864-015-1252-7.
130. Siefert JL. 2009. Defining the mobilome. Methods Mol Biol 532:13–27. http://dx.doi.org/10.1007/978-1-60327-853-9_2.
131. Sekulovic O, Garneau JR, Neron A, Fortier LC. 2014. Characterization of temperate phages infecting Clostridium difficile isolates of human and animal origins. Appl Environ Microbiol 80:2555–2563. http://dx.doi.org/10.1128/AEM.00237-14.
132. Hargreaves KR, Colvin HV, Patel KV, Clokie JJ, Clokie MR. 2013. Genetically diverse Clostridium difficile strains harboring abundant prophages in an estuarine environment. Appl Environ Microbiol 79:6236–6243. http://dx.doi.org/10.1128/AEM.01849-13.
133. Fortier LC, Moineau S. 2007. Morphological and genetic diversity of temperate phages in Clostridium difficile. Appl Environ Microbiol 73: 7358–7366. http://dx.doi.org/10.1128/AEM.00582-07.
134. Hargreaves KR, Kropinski AM, Clokie MR. 2014. What does the talking? Quorum sensing signalling genes discovered in a bacteriophage genome. PLoS One 9:e85131. http://dx.doi.org/10.1371/journal.pone.0085131.
135. Hargreaves KR, Flores CO, Lawley TD, Clokie MR. 2014. Abundant and diverse clustered regularly interspaced short palindromic repeat spacers in Clostridium difficile strains and prophages target multiple phage types within this pathogen. mBio 5(5):e01045-13. http://dx.doi.org/10.1128/mBio.01045-13.
136. Jansen R, Embden JD, Gaastra W, Schouls LM. 2002. Identification of genes that are associated with DNA repeats in prokaryotes. Mol Microbiol 43:1565–1575. http://dx.doi.org/10.1046/j.1365-2958.2002.02839.x.
137. Brouwer MS, Roberts AP, Hussain H, Williams RJ, Allan E, Mullany P. 2013. Horizontal gene transfer converts non-toxigenic Clostridium difficile strains into toxin producers. Nat Commun 4:2601. http://dx.doi.org/10.1038/ncomms3601.
138. Hochhut B, Marrero J, Waldor MK. 2000. Mobilization of plasmids and chromosomal DNA mediated by the SXT element, a constin found in Vibrio cholerae O139. J Bacteriol 182:2043–2047. http://dx.doi.org/10.1128/JB.182.7.2043-2047.2000.
139. Whittle G, Hamburger N, Shoemaker NB, Salyers AA. 2006. A Bacteroides conjugative transposon, CTnERL, can transfer a portion of itself by conjugation without excising from the chromosome. J Bacteriol 188: 1169–1174. http://dx.doi.org/10.1128/JB.188.3.1169-1174.2006.
140. Popoff MR, Bouvet P. 2013. Genetic characteristics of toxigenic Clostridia and toxin gene evolution. Toxicon 75:63–89. http://dx.doi.org/10.1016/j.toxicon.2013.05.003.
141. O’Neill GL, Ogunsola FT, Brazier JS, Duerden BI. 1996. Modification of a PCR ribotyping method for application as a routine typing scheme for Clostridium difficile. Anaerobe 2:205–209. http://dx.doi.org/10.1006/anae.1996.0028.
142. Hashimoto JG, Stevenson BS, Schmidt TM. 2003. Rates and consequences of recombination between rRNA operons. J Bacteriol 185:966–972. http://dx.doi.org/10.1128/JB.185.3.966-972.2003.
143. Cerquetti M, Molinari A, Sebastianelli A, Diociaiuti M, Petruzzelli R, Capo C, Mastrantonio P. 2000. Characterization of surface layer proteins from different Clostridium difficile clinical isolates. Microb Pathog 28:363–372. http://dx.doi.org/10.1006/mpat.2000.0356.
144. Spigaglia P, Barketi-Klai A, Collignon A, Mastrantonio P, Barbanti F, Rupnik M, Janezic S, Kansau I. 2013. Surface-layer (S-layer) of human and animal Clostridium difficile strains and their behaviour in adherence to epithelial cells and intestinal colonization. J Med Microbiol 62:1386–1393. http://dx.doi.org/10.1099/jmm.0.056556-0.
145. Kryazhimskiy S, Plotkin JB. 2008. The population genetics of dN/dS. PLoS Genet 4:e1000304. http://dx.doi.org/10.1371/journal.pgen.1000304.
146. Elliott B, Dingle KE, Didelot X, Crook D, Riley TV. 2014. The complexity and diversity of the pathogenicity locus in Clostridium difficile clade 5. Genome Biol Evol 6:3159–3170. http://dx.doi.org/10.1093/gbe/evu248.
147. Castillo-Ramirez S, Harris SR, Holden MT, He M, Parkhill J, Bentley SD, Feil EJ. 2011. The impact of recombination on dN/dS within recently emerged bacterial clones. PLoS Pathog 7:e1002129. http://dx.doi.org/10.1371/journal.ppat.1002129.
148. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, Rene P, Monczak Y, Dascal A. 2005. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353:2442–2449. http://dx.doi.org/10.1056/NEJMoa051639.
149. Clements ACA, Magalhaes RJS, Tatem AJ, Paterson DL, Riley TV. 2010. Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread. Lancet Infect Dis 10:395–404. http://dx.doi.org/10.1016/S1473-3099(10)70080-3.
150. Mooney H. 2007. Annual incidence of MRSA falls in England, but C. difficile continues to rise. BMJ 335:958. http://dx.doi.org/10.1136/bmj.39388.597569.DB.
151. Healthcare Commission. 2006. Investigation into outbreaks of Clostridium difficile at Stoke Mandeville Hospital, Buckinghamshire Hospitals NHS Trust. Commission for Healthcare Audit and Inspection, London, United Kingdom. http://www.buckinghamshirehospitals.nhs.uk/healthcarecommision/HCC-Investigation-into-the-Outbreak-of-Clostridium-difficile.pdf.
152. von Eichel-Streiber C, Laufenberg-Feldmann R, Sartingen S, Schulze J, Sauerborn M. 1992. Comparative sequence analysis of the Clostridium difficile toxins A and B. Mol Gen Genet 233:260–268.
153. Moore P, Kyne L, Martin A, Solomon K. 2013. Germination efficiency of clinical Clostridium difficile spores and correlation with ribotype, disease severity and therapy failure. J Med Microbiol 62:1405–1413. http://dx.doi.org/10.1099/jmm.0.056614-0.
154. Burns DA, Heap JT, Minton NP. 2010. The diverse sporulation characteristics of Clostridium difficile clinical isolates are not associated with type. Anaerobe 16:618–622. http://dx.doi.org/10.1016/j.anaerobe.2010.10.001.
155. Lanis JM, Barua S, Ballard JD. 2010. Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile. PLoS Pathog 6:e1001061. http://dx.doi.org/10.1371/journal.ppat.1001061.
156. Ackermann G, Tang YJ, Kueper R, Heisig P, Rodloff AC, Silva J, Cohen SH. 2001. Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA. Antimicrob Agents Chemother 45:2348–2353. http://dx.doi.org/10.1128/AAC.45.8.2348-2353.2001.
157. Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, Kuijper EJ, Wilcox MH. 2010. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 23:529–549. http://dx.doi.org/10.1128/CMR.00082-09.
158. Pépin J, Saheb N, Coulombe M, Alary M, Corriveau M, Authier S, Leblanc M, Rivard G, Bettez M, Primeau V. 2005. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficileassociated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41:1254–1260. http://dx.doi.org/10.1086/496986.
159. De Almeida MN, Heffernan H, Dervan A, Bakker S, Freeman JT, Bhally H, Taylor SL, Riley TV, Roberts SA. 2013. Severe Clostridium difficile infection in New Zealand associated with an emerging strain, PCR-ribotype 244. N Z Med J 126:9–14.
160. Eyre DW, Tracey L, Elliott B, Slimings C, Huntington PG, Stuart RL, Korman TM, Kotsiou G, McCann R, Griffiths D, Fawley WN, Armstrong P, Dingle KE, Walker AS, Peto TE, Crook DW, Wilcox MH, Riley TV. 2015. Emergence and spread of predominantly communityonset Clostridium difficile PCR ribotype 244 infection in Australia, 2010 to 2012. Euro Surveill 20(10):pii_21059. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId_21059.
161. Riley TV. 2004. Nosocomial diarrhoea due to Clostridium difficile. Curr Opin Infect Dis 17:323–327. http://dx.doi.org/10.1097/01.qco.0000136930.83167.9b.
162. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. 1989. Nosocomial acquisition of Clostridium difficile infection. NEngl J Med 320:204–210. http://dx.doi.org/10.1056/NEJM198901263200402.
163. Vonberg RP, Kuijper EJ, Wilcox MH, Barbut F, Tull P, Gastmeier P, van den Broek PJ, Colville A, Coignard B, Daha T, Debast S, Duerden BI, van den Hof S, van der Kooi T, Maarleveld HJ, Nagy E, Notermans DW, O’Driscoll J, Patel B, Stone S, Wiuff C. 2008. Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect 14(Suppl 5):2–20. http://dx.doi.org/10.1111/j.1469-0691.2008.01992.x.
164. Noren T, Akerlund T, Back E, Sjoberg L, Persson I, Alriksson I, Burman LG. 2004. Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol 42:3635–3643. http://dx.doi.org/10.1128/JCM.42.8.3635-3643.2004.
165. Walker AS, Eyre DW, Wyllie DH, Dingle KE, Harding RM, O’Connor L, Griffiths D, Vaughan A, Finney J, Wilcox MH, Crook DW, Peto TEA. 2012. Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing. PLoS Med 9:e1001172. http://dx.doi.org/10.1371/journal.pmed.1001172.
166. Didelot X, Eyre DW, Cule M, Ip CL, Ansari MA, Griffiths D, Vaughan A, O’Connor L, Golubchik T, Batty EM, Piazza P, Wilson DJ, Bowden R, Donnelly PJ, Dingle KE, Wilcox M, Walker AS, Crook DW, Peto TE, Harding RM. 2012. Microevolutionary analysis of Clostridium difficile genomes to investigate transmission. Genome Biol 13:R118. http://dx.doi.org/10.1186/gb-2012-13-12-r118.
167. Eyre DW, Cule ML, Wilson DJ, Griffiths D, Vaughan A, O’Connor L, Ip CL, Golubchik T, Batty EM, Finney JM, Wyllie DH, Didelot X, Piazza P, Bowden R, Dingle KE, Harding RM, Crook DW, Wilcox MH, Peto TE, Walker AS. 2013. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med 369:1195–1205. http://dx.doi.org/10.1056/NEJMoa1216064.
168. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, Zuckerbraun BS. 2013. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 108:478–498. http://dx.doi.org/10.1038/ajg.2013.4.
169. Pepin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, Godin D, Bourassa C. 2005. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 40:1591–1597. http://dx.doi.org/10.1086/430315.
170. Figueroa I, Johnson S, Sambol SP, Goldstein EJ, Citron DM, Gerding DN. 2012. Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin. Clin Infect Dis 55:S104–S109. http://dx.doi.org/10.1093/cid/cis357.
171. Eyre DW, Babakhani F, Griffiths D, Seddon J, Del Ojo Elias C, Gorbach SL, Peto TE, Crook DW, Walker AS. 2014. Whole-genome sequencing demonstrates that fidaxomicin is superior to vancomycin for preventing reinfection and relapse of infection with Clostridium difficile. J Infect Dis 209:1446–1451. http://dx.doi.org/10.1093/infdis/jit598.
172. Khanna S, Pardi DS. 2012. Community-acquired Clostridium difficile infection: an emerging entity. Clin Infect Dis 55:1741–1742. http://dx.doi.org/10.1093/cid/cis722.
173. Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R, St Sauver JL, Harmsen WS, Zinsmeister AR. 2012. The epidemiology of community- acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol 107:89–95. http://dx.doi.org/10.1038/ajg.2011.398.
174. Kuntz JL, Chrischilles EA, Pendergast JF, Herwaldt LA, Polgreen PM. 2011. Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study. BMC Infect Dis 11: 194. http://dx.doi.org/10.1186/1471-2334-11-194.
175. Squire MM, Riley TV. 2012. Clostridium difficile infection: the next big thing! Microbiol Aus 33:163–164.
176. Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C, Notermans DW, Bergwerff AA, Dekker FW, Kuijper EJ. 2008. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 47:1162–1170. http://dx.doi.org/10.1086/592257.
177. Stewart DB, Berg AS, Hegarty JP. 2014. Single nucleotide polymorphisms of the tcdC gene and presence of the binary toxin gene predict recurrent episodes of Clostridium difficile infection. Ann Surg 260:299–304. http://dx.doi.org/10.1097/SLA.0000000000000469.
178. Hensgens MP, Keessen EC, Squire MM, Riley TV, Koene MG, de Boer E, Lipman LJ, Kuijper EJ. 2012. Clostridium difficile infection in the community: a zoonotic disease? Clin Microbiol Infect 18:635–645. http://dx.doi.org/10.1111/j.1469-0691.2012.03853.x.
179. Songer JG, Anderson MA. 2006. Clostridium difficile: an important pathogen of food animals. Anaerobe 12:1–4. http://dx.doi.org/10.1016/j.anaerobe.2005.09.001.
180. Keessen EC, Gaastra W, Lipman LJ. 2011. Clostridium difficile infection in humans and animals, differences and similarities. Vet Microbiol 153: 205–217. http://dx.doi.org/10.1016/j.vetmic.2011.03.020.
181. Pasquale V, Romano V, Rupnik M, Capuano F, Bove D, Aliberti F, Krovacek K, Dumontet S. 2012. Occurrence of toxigenic Clostridium difficile in edible bivalve molluscs. Food Microbiol 31:309–312. http://dx.doi.org/10.1016/j.fm.2012.03.001.
182. Zidaric V, Zemljic M, Janezic S, Kocuvan A, Rupnik M. 2008. High diversity of Clostridium difficile genotypes isolated from a single poultry farm producing replacement laying hens. Anaerobe 14:325–327. http://dx.doi.org/10.1016/j.anaerobe.2008.10.001.
183. Weese JS, Wakeford T, Reid-Smith R, Rousseau J, Friendship R. 2010. Longitudinal investigation of Clostridium difficile shedding in piglets. Anaerobe 16:501–504. http://dx.doi.org/10.1016/j.anaerobe.2010.08.001.
184. Weese JS, Finley R, Reid-Smith RR, Janecko N, Rousseau J. 2010. Evaluation of Clostridium difficile in dogs and the household environment. Epidemiol Infect 138:1100–1104. http://dx.doi.org/10.1017/S0950268809991312.
185. Weese JS, Armstrong J. 2003. Outbreak of Clostridium difficileassociated disease in a small animal veterinary teaching hospital. J Vet Intern Med 17:813–816. http://dx.doi.org/10.1111/j.1939-1676.2003.tb02519.x.
186. Thean S, Elliott B, Riley TV. 2011. Clostridium difficile in horses in Australia—a preliminary study. J Med Microbiol 60:1188–1192. http://dx.doi.org/10.1099/jmm.0.030908-0.
187. Schneeberg A, Neubauer H, Schmoock G, Grossmann E, Seyboldt C. 2013. Presence of Clostridium difficile PCR ribotype clusters related to 033, 078 and 045 in diarrhoeic calves in Germany. J Med Microbiol 62:1190–1198. http://dx.doi.org/10.1099/jmm.0.056473-0.
188. Rupnik M, Widmer A, Zimmermann O, Eckert C, Barbut F. 2008. Clostridium difficile toxinotype V, ribotype 078, in animals and humans. J Clin Microbiol 46:2146. http://dx.doi.org/10.1128/JCM.00598-08.
189. Riley TV, Adams JE, O’Neill GL, Bowman RA. 1991. Gastrointestinal carriage of Clostridium difficile in cats and dogs attending veterinary clinics. Epidemiol Infect 107:659–665. http://dx.doi.org/10.1017/S0950268800049359.
190. Medina-Torres CE, Weese JS, Staempfli HR. 2011. Prevalence of Clostridium difficile in horses. Vet Microbiol 152:212–215. http://dx.doi.org/10.1016/j.vetmic.2011.04.012.
191. Knight DR, Riley TV. 2013. Prevalence of gastrointestinal Clostridium difficile carriage in Australian sheep and lambs. Appl Environ Microbiol 79:5689–5692. http://dx.doi.org/10.1128/AEM.01888-13.
192. Indra A, Lassnig H, Baliko N, Much P, Fiedler A, Huhulescu S, Allerberger F. 2009. Clostridium difficile: a new zoonotic agent? Wien Klin Wochenschr 121:91–95. http://dx.doi.org/10.1007/s00508-008-1127-x.
193. Hopman NE, Keessen EC, Harmanus C, Sanders IM, van Leengoed LAMG, Kuijper EJ, Lipman LJ. 2011. Acquisition of Clostridium difficile by piglets. Vet Microbiol 149:186–192. http://dx.doi.org/10.1016/j.vetmic.2010.10.013.
194. Costa MC, Stampfli HR, Arroyo LG, Pearl DL, Weese JS. 2011. Epidemiology of Clostridium difficile on a veal farm: prevalence, molecular characterization and tetracycline resistance. Vet Microbiol 152:379–384. http://dx.doi.org/10.1016/j.vetmic.2011.05.014.
195. Avbersek J, Janezic S, Pate M, Rupnik M, Zidaric V, Logar K, Vengust M, Zemljic M, Pirs T, Ocepek M. 2009. Diversity of Clostridium difficile in pigs and other animals in Slovenia. Anaerobe 15:252–255. http://dx.doi.org/10.1016/j.anaerobe.2009.07.004.
196. Alvarez-Perez S, Blanco JL, Martinez-Nevado E, Pelaez T, Harmanus C, Kuijper E, Garcia ME. 2014. Shedding of Clostridium difficile PCR ribotype 078 by zoo animals, and report of an unstable metronidazoleresistant isolate from a zebra foal (Equus quagga burchellii). Vet Microbiol 169:218–222. http://dx.doi.org/10.1016/j.vetmic.2013.12.018.
197. Debast SB, van Leengoed LA, Goorhuis A, Harmanus C, Kuijper EJ, Bergwerff AA. 2009. Clostridium difficile PCR ribotype 078 toxinotype V found in diarrhoeal pigs identical to isolates from affected humans. Environ Microbiol 11:505–511. http://dx.doi.org/10.1111/j.1462-2920.2008.01790.x.
198. Rodriguez-Palacios A, Stampfli HR, Duffield T, Peregrine AS, Trotz- Williams LA, Arroyo LG, Brazier JS, Weese JS. 2006. Clostridium difficile PCR ribotypes in calves, Canada. Emerg Infect Dis 12:1730–1736. http://dx.doi.org/10.3201/eid1211.051581.
199. Keel K, Brazier JS, Post KW, Weese S, Songer JG. 2007. Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species. J Clin Microbiol 45:1963–1964. http://dx.doi.org/10.1128/JCM.00224-07.
200. Rupnik M, Songer JG. 2010. Clostridium difficile: its potential as a source of foodborne disease. Adv Food Nutr Res 60:53–66. http://dx.doi.org/10.1016/S1043-4526(10)60003-4.
201. Weese JS. 2010. Clostridium difficile in food—innocent bystander or serious threat? Clin Microbiol Infect 16:3–10. http://dx.doi.org/10.1111/j.1469-0691.2009.03108.x.
202. Songer JG, Trinh HT, Killgore GE, Thompson AD, McDonald LC, Limbago BM. 2009. Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis 15:819–821. http://dx.doi.org/10.3201/eid1505.081071.
203. Rupnik M. 2010. Clostridium difficile: (re)emergence of zoonotic potential. Clin Infect Dis 51:583–584. http://dx.doi.org/10.1086/655693.
204. Knight DR, Squire MM, Riley TV. 2015. Nationwide surveillance study of Clostridium difficile in Australian neonatal pigs shows high prevalence and heterogeneity of PCR ribotypes. Appl Environ Microbiol 81:119–123. http://dx.doi.org/10.1128/AEM.03032-14.
205. Squire MM, Riley TV. 2013. Clostridium difficile infection in humans and piglets: a ‘One Health’ opportunity. Curr Top Microbiol Immunol 365:299–314. http://dx.doi.org/10.1007/82_2012_237.
206. Riley TV. 2009. Is Clostridium difficile a threat to Australia’s biosecurity? Med J Aust 190:661–662.
207. Bakker D, Corver J, Harmanus C, Goorhuis A, Keessen EC, Fawley WN, Wilcox MH, Kuijper EJ. 2010. Relatedness of human and animal Clostridium difficile PCR ribotype 078 isolates determined on the basis of multilocus variable-number tandem-repeat analysis and tetracycline resistance. J Clin Microbiol 48:3744–3749. http://dx.doi.org/10.1128/JCM.01171-10.
208. Knetsch CW, Connor TR, Mutreja A, van Dorp SM, Sanders IM, Browne HP, Harris D, Lipman L, Keessen EC, Corver J, Kuijper EJ, Lawley TD. 2014. Whole genome sequencing reveals potential spread of Clostridium difficile between humans and farm animals in the Netherlands, 2002 to 2011. Euro Surveill 19(45):pii_20954. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId_20954.